Zhejiang Cancer Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Zhejiang Cancer Hospital
RECRUITINGPhase 2NCT07330544
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone...
* This study was an open, multicenter phase II clinical trial that enrolled 118 patients with HR+/HER2- with recurrent or progressive advanced breast cancer treated with CDK4/6...
Sponsor: Zhejiang Cancer HospitalEnrolling: 1181 location
Breast Cancer
RECRUITINGPhase 3NCT06214195
The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
To evaluate the effectiveness and safety of Shengmai San in preventing anthracycline sequential trastuzumab therapy related cardiac toxicity through a prospective randomized...
Sponsor: Zhejiang Cancer HospitalEnrolling: 2761 location
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
RECRUITINGPhase 2NCT06562920
Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung...
To explore the effectiveness and safety of adebrelimab combined with chemotherapy and concurrent SBRT for 3 cycles of neoadjuvant treatment followed by surgery in T1-3N0-1M0...
Sponsor: Zhejiang Cancer HospitalEnrolling: 201 location
Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer